Showing results (591-600 of 3,788) with videos related to

Sort By:
Pageof 379
Oncoimmunology|September 16, 2020
IL15 synergizes with radiotherapy to reprogram the tumor immune contexture through a dendritic cell connectionKarsten A Pilones, Maud Charpentier, Elena Garcia-Martinez, et al.
Oncoimmunology|September 16, 2020
Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitorsRomain Daillère, Bertrand Routy, Anne-Gaëlle Goubet, et al.
Oncoimmunology|September 14, 2020
Intravital imaging reveals synergistic effect of CAR T-cells and radiation therapy in a preclinical immunocompetent glioblastoma modelSurya Murty, Samuel T Haile, Corinne Beinat, et al.
Oncoimmunology|September 14, 2020
ROS1-fusion protein induces PD-L1 expression via MEK-ERK activation in non-small cell lung cancerZheng Liu, Kejia Zhao, Shiyou Wei, et al.
Oncoimmunology|September 14, 2020
Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcomeKim L Brunekreeft, Sterre T Paijens, Maartje C A Wouters, et al.
Oncoimmunology|September 14, 2020
Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibitionVictor Cervera-Carrascon, Dafne C A Quixabeira, Joao Manuel Santos, et al.
Oncoimmunology|September 14, 2020
A rationally-engineered IL-2 improves the antitumor effect of anti-CD20 therapyAna Victoria Casadesús, Claire Deligne, Béré Kadjdiatou Diallo, et al.
Oncoimmunology|September 14, 2020
Tumor mutational burden is not predictive of cytotoxic chemotherapy responseMina Nikanjam, Paul Riviere, Aaron Goodman, et al.
Oncoimmunology|September 14, 2020
Systemic inflammation is associated with circulating cell death released keratin 18 fragments in colorectal cancerPäivi Sirniö, Juha P Väyrynen, Shivaprakash J Mutt, et al.
Oncoimmunology|September 14, 2020
Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccinationTanja Lövgren, Maria Wolodarski, Stina Wickström, et al.
Pageof 379